VIOPHTAN NR 14 - Bioregulator of Eye Arteries

VIOPHTAN NR 14 is a protein-peptide eye balm. Targeted peptide-based modulator of the visual analyzer. Used as eye drops.

Indications for use:

• For macular degeneration, retinopathy, and vascular eye diseases: thrombosis, sclerosis, hemophthalmos, diabetic retinopathy;
• During the rehabilitation period after vascular eye diseases and surgeries.

Composition:

Protein-peptide bioregulator of animal origin, isolated from the aorta of cattle (Bos Taurus), calcium chloride, sodium chloride, demineralized water.

Physiological action:

• Improves the condition of the blood vessels in the fundus;
• Strengthens the walls of the ocular arteries.

Mode of application:

Viophtan is instilled into the eyes, 1-2 drops at a time, 2-4-7 times, depending on the condition.

Different Viophtans are instilled at intervals of at least 10 minutes.

Benefits:

• Do not cause allergic reactions;
• Do not cause overdoses (no toxic or even dyspeptic dose);
• Do not have side effects or contraindications;
• Facilitate the restoration of the normal structure and function of pathologically altered tissues and are resistant to a number of physicochemical factors;
• Compatible with any pharmacotherapy (including antibiotics, chemotherapy), radiation therapy, and physical therapy, as they are resistant to a number of physicochemical factors;
• Compatible with any naturopathic method - phytotherapy, hirudotherapy, and homeopathic remedies;
• Can be administered at any stage of the disease and inflammatory process;
• If necessary, several Viorgons and Viophtans can be prescribed simultaneously to correct and prevent multiple conditions;
• Viorgons and Viophtans are non-addictive (which is important for long-term management of chronic diseases).

Release form: 15ml (~ 300 drops)

Contraindications: None.

Side effects: None.

Addiction: None.

Shelf life: 2 years

This is not a medicine. It is recommended to consult a doctor before using this product.

Guaranteed authenticity and quality:

100% Original from the Institute of Bioregulation Problems (Russian Federation).

The Institute of Bioregulation Problems is a private research and production company specializing in the development of protein-peptide complexes and bioregulatory agents (MGTBio).

We also conduct research and development, collaborating with various Russian Academy of Sciences institutes and medical organizations.

To date, we have published over 250 scientific papers and received over 10 patents on protein-peptide bioregulator research.

Development and production:

INSTITUTE OF BIOREGULATION PROBLEMS (Produced in Russia)